GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2018;392(10152):1015–35. https://doi.org/10.1016/S0140-6736(18)31310-2.
Rehm J, Shield KD. Global burden of disease and the impact of mental and addictive disorders. Curr Psychiatry Rep. 2019;21(2):10. https://doi.org/10.1007/s11920-019-0997-0.
Carvalho AF, Heilig M, Perez A, Probst C, Rehm J. Alcohol use disorders. Lancet. 2019;394(10200):781–92. https://doi.org/10.1016/S0140-6736(19)31775-1.
National survey on drug use and health. Available from www.samhsa.gov/data. Accessed November 15, 2015.
Shield KD, Rehm J. Alcohol and the global burden of disease. Lancet. 2019;393(10189):2390. https://doi.org/10.1016/S0140-6736(19)30726-3.
Gonzales K, Roeber J, Kanny D, Tran A, Saiki C, Johnson H, et al. Alcohol-attributable deaths and years of potential life lost-11 States, 2006–2010. MMWR Morb Mortal Wkly Rep. 2014;63(10):213–6.
Westman J, Wahlbeck K, Laursen TM, Gissler M, Nordentoft M, Hallgren J, et al. Mortality and life expectancy of people with alcohol use disorder in Denmark, Finland and Sweden. Acta Psychiatr Scand. 2015;131(4):297–306. https://doi.org/10.1111/acps.12330.
Clark BJ, Keniston A, Douglas IS, Beresford T, Macht M, Williams A, et al. Healthcare utilization in medical intensive care unit survivors with alcohol withdrawal. Alcohol Clin Exp Res. 2013;37(9):1536–43. https://doi.org/10.1111/acer.12124.
Carlson RW, Kumar NN, Wong-Mckinstry E, Ayyagari S, Puri N, Jackson FK, et al. Alcohol withdrawal syndrome. Crit Care Clin. 2012;28(4):549–85. https://doi.org/10.1016/j.ccc.2012.07.004.
Lindenauer PK, Normand SL, Drye EE, Lin Z, Goodrich K, Desai MM, et al. Development, validation, and results of a measure of 30-day readmission following hospitalization for pneumonia. J Hosp Med. 2011;6(3):142–50. https://doi.org/10.1002/jhm.890.
Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, et al. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: a systematic review. Int J Endocrinol. 2020;2020:4678526. https://doi.org/10.1155/2020/4678526.
Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304. https://doi.org/10.1089/met.2008.0034.
Pan DA, Lillioja S, Kriketos AD, et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes. 1997;46(6):983–8. https://doi.org/10.2337/diab.46.6.983.
Wu S, Xu L, Wu M, Chen S, Wang Y, Tian Y. Association between triglyceride-glucose index and risk of arterial stiffness: a cohort study. Cardiovasc Diabetol. 2021;20(1):146. https://doi.org/10.1186/s12933-021-01342-2.
Huang Z, Ding X, Yue Q, Wang X, Chen Z, Cai Z, et al. Triglyceride-glucose index trajectory and stroke incidence in patients with hypertension: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):141. https://doi.org/10.1186/s12933-022-01577-7.
Tian X, Zuo Y, Chen S, Liu Q, Tao B, Wu S, et al. Triglyceride-glucose index is associated with the risk of myocardial infarction: an 11-year prospective study in the Kailuan cohort. Cardiovasc Diabetol. 2021;20(1):19. https://doi.org/10.1186/s12933-020-01210-5.
Sun J, Xie Z, Wu Y, Liu X, Ma J, Dong Y, et al. Association of the triglyceride-glucose index with risk of alzheimer’s disease: a prospective cohort study. Am J Prev Med. 2023;65(6):1042–9. https://doi.org/10.1016/j.amepre.2023.07.011.
Moon S, Park JS, Ahn Y. The cut-off values of triglycerides and glucose index for metabolic syndrome in American and Korean adolescents. J Korean Med Sci. 2017;32(3):427–33. https://doi.org/10.3346/jkms.2017.32.3.427.
Askgaard G, Gronbaek M, Kjaer MS, Tjonneland A, Tolstrup JS. Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study. J Hepatol. 2015;62:1061–7. https://doi.org/10.1016/j.jhep.2014.12.005.
Toma A, Pare G, Leong DP. Alcohol and cardiovascular disease: how much is too much? Curr Atheroscler Rep. 2017;19:13. https://doi.org/10.1007/s11883-017-0647-0.
Klop B, Do Rego AT, Cabezas MC. Alcohol and plasma triglycerides. Curr Opin Lipidol. 2013;24(4):321–6. https://doi.org/10.1097/MOL.0b013e3283606845.
Athyros VG, Liberopoulos EN, Mikhailidis DP, Papageorgiou AA, Ganotakis ES, Tziomalos K, Kakafika AI, Karagiannis A, Lambropoulos S, Elisaf M. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort. Angiology. 2007;58:689–97. https://doi.org/10.1177/0003319707306146.
Faulkner ML, Momenan R, Leggio L. A neuroimaging investigation into the role of peripheral metabolic biomarkers in the anticipation of reward in alcohol use. Drug Alcohol Depend. 2021;221: 108638. https://doi.org/10.1016/j.drugalcdep.2021.108638.
Mattoo SK, Nebhinani N, Aggarwal M, Basu D, Kulhara P. Metabolic syndrome among substance dependent men: a study from north India. Ind Psychiatry J. 2013;22:60–4. https://doi.org/10.4103/0972-6748.123631.
Leggio L, Ray LA, Kenna GA, Swift RM. Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the combined pharmacotherapies and behavioral interventions for alcohol dependence (COMBINE) study. Alcohol Clin Exp Res. 2009;33:1539–44. https://doi.org/10.1111/j.1530-0277.2009.00982.x.
Goodyear K, Lee MR, Schwandt ML, Hodgkinson CA, Leggio L. Hepatic, lipid and genetic factors associated with obesity: crosstalk with alcohol dependence? World J Biol Psychiatry. 2017;18:120–8. https://doi.org/10.1080/15622975.2016.1249952.
Jarvis CM, Hayman LL, Braun LT, Schwertz DW, Ferrans CE, Piano MR. Cardiovascular risk factors and metabolic syndrome in alcohol- and nicotine-dependent men and women. J Cardiovasc Nurs. 2007;22:429–35. https://doi.org/10.1097/01.Jcn.0000297387.21626.88.
Singh JA, Cleveland JD. Trends in hospitalizations for alcohol use disorder in the US from 1998 to 2016. JAMA Netw Open. 2020;3(9):e2016580. https://doi.org/10.1001/jamanetworkopen.2020.16580.
Zhang R, Shi S, Chen W, Wang Y, Lin X, Zhao Y, et al. Independent effects of the triglyceride-glucose index on all-cause mortality in critically ill patients with coronary heart disease: analysis of the MIMIC-III database. Cardiovasc Diabetol. 2023;22(1):10. https://doi.org/10.1186/s12933-023-01737-3.
Liao Y, Zhang R, Shi S, Zhao Y, He Y, Liao L, et al. Triglyceride-glucose index linked to all-cause mortality in critically ill patients: a cohort of 3026 patients. Cardiovasc Diabetol. 2022;21(1):128. https://doi.org/10.1186/s12933-022-01563-z.
Odegaard JI, Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science. 2013;339(6116):172–7. https://doi.org/10.1126/science.1230721.
Adeva-Andany MM, Martínez-Rodríguez J, González-Lucán M, Fernández-Fernández C, Castro-Quintela E. Insulin resistance is a cardiovascular risk factor in humans. Diabetes Metab Syndr. 2019;13(2):1449–55. https://doi.org/10.1016/j.dsx.2019.02.023.
Zauner A, Nimmerrichter P, Anderwald C, Bischof M, Schiefermeier M, Ratheiser K, et al. Severity of insulin resistance in critically ill medical patients. Metabolism. 2007;56(1):1–5. https://doi.org/10.1016/j.metabol.2006.08.014.
Navarro-González D, Sánchez-Íñigo L, Pastrana-Delgado J, Fernández-Montero A, Martinez JA. Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: the vascular-metabolic CUN cohort. Prev Med. 2016;86:99–105. https://doi.org/10.1016/j.ypmed.2016.01.022.
Jin JL, Cao YX, Wu LG, You XD, Guo YL, Wu NQ, et al. Triglyceride glucose index for predicting cardiovascular outcomes in patients with coronary artery disease. J Thorac Dis. 2018;10(11):6137–46. https://doi.org/10.21037/jtd.2018.10.79.
Sánchez-Íñigo L, Navarro-González D, Fernández-Montero A, Pastrana-Delgado J, Martínez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46(2):189–97. https://doi.org/10.1111/eci.12583.
Zhang Y, Ding X, Hua B, Liu Q, Gao H, Chen H, et al. High triglyceride-glucose index is associated with poor cardiovascular outcomes in nondiabetic patients with ACS with LDL-C below 1.8 mmol/L. J Atheroscler Thromb. 2022;29(2):268–81. https://doi.org/10.5551/jat.61119.
Yang S, Du Y, Liu Z, Zhang R, Lin X, Ouyang Y, et al. Triglyceride-glucose index and extracellular volume fraction in patients with heart failure. Front Cardiovasc Med. 2021;8:704462. https://doi.org/10.3389/fcvm.2021.704462.
Wang Z, Qian H, Zhong S, Gu T, Xu M, Yang Q. The relationship between triglyceride-glucose index and albuminuria in United States adults. Front Endocrinol (Lausanne). 2023;14:1215055. https://doi.org/10.3389/fendo.2023.1215055.
Qin Z, Zhao J, Geng J, Chang K, Liao R, Su B. Higher triglyceride-glucose index is associated with increased likelihood of kidney stones. Front Endocrinol (Lausanne). 2021;12:774567. https://doi.org/10.3389/fendo.2021.774567.
Liu R, Li L, Wang L, Zhang S. Triglyceride-glucose index predicts death in patients with stroke younger than 65. Front Neurol. 2023;14:1198487. https://doi.org/10.3389/fneur.2023.1198487.
Khan SH, Sobia F, Niazi NK, Manzoor SM, Fazal N, Ahmad F. Metabolic clustering of risk factors: evaluation of triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetol Metab Syndr. 2018;10:74. https://doi.org/10.1186/s13098-018-0376-8.
Yang Q, Vijayakumar A, Kahn BB. Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol. 2018;19(10):654–72. https://doi.org/10.1038/s41580-018-0044-8.
Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016;126(1):12–22. https://doi.org/10.1172/JCI77812.
Nishikawa T, Kukidome D, Sonoda K, Fujisawa K, Matsuhisa T, Motoshima H, et al. Impact of mitochondrial ROS production in the pathogenesis of insulin resistance. Diabetes Res Clin Pract. 2007;77(Suppl 1):S161–4. https://doi.org/10.1016/j.diabres.2007.01.071.
Molina MN, Ferder L, Manucha W. Emerging role of nitric oxide and heat shock proteins in insulin resistance. Curr Hypertens Rep. 2016;18(1):1. https://doi.org/10.1007/s11906-015-0615-4.
Gerrits AJ, Koekman CA, van Haeften TW, Akkerman JW. Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin. Diabetes. 2010;59(6):1487–95. https://doi.org/10.2337/db09-1008.
Nakagawa T. Uncoupling of VEGF with NO as a mechanism for diabetic nephropathy. Diabetes Res Clin Pract. 2008;82(Suppl 1):S67–9. https://doi.org/10.1016/j.diabres.2008.09.030.
Shimobayashi M, Albert V, Woelnerhanssen B, Frei IC, Weissenberger D, Meyer-Gerspach AC, et al. Insulin resistance causes inflammation in adipose tissue. J Clin Invest. 2018;128(4):1538–50. https://doi.org/10.1172/JCI96139.
Liao L, Pinhu L. Red blood cell distribution width as a predictor of 28-day mortality in critically ill patients with alcohol use disorder. Alcohol Clin Exp Res. 2020;44(12):2555–60. https://doi.org/10.1111/acer.14483.
Pan Y, Miao X, Jin O, Pan J, Dong Y. Association of plasma anion gap with 28-day inhospital mortality and 1-year mortality of patients with alcohol use disorder at ICU admission: a retrospective cohort study. Dis Markers. 2022;2022:5039964. https://doi.org/10.1155/2022/5039964.
Fuster D, Sanvisens A, Bolao F, Zuluaga P, Rivas I, Tor J, et al. Markers of inflammation and mortality in a cohort of patients with alcohol dependence. Medicine (Baltimore). 2015;94(10):e607. https://doi.org/10.1097/MD.0000000000000607.
Add Comment